CDC/ACIP [to 2 Mar 2019]
Wednesday, February 27, 2019
CDC data confirm: Progress in HIV prevention has stalled
Need for immediate action —‘Ending the Epidemic: A Plan for America’
The dramatic decline in annual HIV infections has stopped and new infections have stabilized in recent years, according to a CDC report published today.
The report provides the most recent data on HIV trends in America from 2010 to 2016. It shows that after about five years of substantial declines, the number of HIV infections began to level off in 2013 at about 39,000 infections per year.
“Now is the time for our Nation to take bold action. We strongly support President Trump’s plan to end the HIV epidemic in America,” said CDC Director Robert R. Redfield, M.D. “We must move beyond the status quo to end the HIV epidemic in America.”…
MMWR News Synopsis for March 1, 2019
Progress toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus — Western Pacific Region, 2005–2017
Hepatitis B vaccination significantly reduced hepatitis B infections among children in the Western Pacific Region, from 8 percent (considered a high endemicity rate) to less than 1 percent (considered a low endemicity rate). Hepatitis B (HepB), a vaccine preventable disease, is a major cause of liver cancer. After all countries/areas in the Western Pacific Region (WPR) introduced the HepB vaccine into childhood immunization schedules, childhood infections dropped from a high of more than 8 percent in 1990 to less than 1 percent by 2017. These remarkable immunization achievements prevented more than 37 million chronic infections and 7 million HepB-related deaths. Further HepB control includes improving HepB birth-dose coverage through increased health facility births, antenatal training, and outside-the-cold-chain use. In addition to maintaining high vaccine coverage, additional interventions like routine antenatal testing, administration of hepatitis B immunoglobulin to exposed newborns, and antiviral treatment of mothers would be needed to achieve elimination of mother-to-child transmission of HepB by 2030.
… The conference, organized jointly by the African Union, Africa Centres for Disease Control and Prevention (Africa CDC) and the World Health Organization (WHO), was well attended by representatives of African Union Member States, other governments outside Africa, the World Bank, United Nations agencies, donor and development organizations, pharmaceutical and drug development organizations, and the media. It is the first of its kind facilitated by Africa CDC.
“Ebola Virus Disease has become more widely spread geographically, causing major health and political crisis. This is the first scientific meeting organized by Africa CDC on Ebola virus,” said Dr Yankuba Kassama, Director of Medical Services, African Union Commission.
The meeting provided an opportunity to update Member States on progress in diagnostics, vaccines and therapeutics preparedness for EVD in Africa and to share experience and lessons from Ebola interventions across the continent.
“This meeting is an excellent platform for Member States to receive update and share experience on efforts towards preparedness to prevent and contain EVD outbreaks in Africa,” said H.E. Dr Amir Aman, Minister of Health Ethiopia and Chair of the Governing Board of Africa CDC.
There were presentations of experiences and lessons from Ebola control efforts in West Africa and other countries, including Ethiopia, Rwanda, Uganda, Zambia, and Democratic Republic of Congo. There were also presentations on the development, availability, use, regulation and perspectives on the EVD vaccines and therapeutics. Extensive discussions were held on current trends in the production, distribution and stockpiling of EVD vaccines and drugs for effective preparedness and response.
Participants identified the need for dialogues and sensitization to increase understanding of the need for stockpiling by countries that have not experienced any Ebola outbreak. They highlighted the need for more research and capacity strengthening for Ebola response and increase in access to the vaccines.